NATURAL ALTERNATIVES INTERNATIONAL INC Segment Expenditure Addition To Long Lived Assets
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Segment Expenditure Addition To Long Lived Assets of $1.10 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-05-19
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $1.10M, a 37.16% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $934.00K, a 11.55% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for the quarter ending 2025-06-30 was $1.46M, a 40.72% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for the quarter ending 2025-03-31 was $802.00K, a 190.58% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for fiscal 2025 was $3.61M, a 19.79% increase from fiscal 2024.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for fiscal 2024 was $3.02M, a 77.69% decline from fiscal 2023.
- NATURAL ALTERNATIVES INTERNATIONAL INC segment expenditure addition to long lived assets for fiscal 2023 was $13.52M.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-19 | $2.03M derived: sum of 2 quarters · filed 2026-05-19 | $3.06M 10-Q · filed 2026-05-19 | |
| 2025-12-31 | $934.00K 10-Q · filed 2026-02-13 | $1.96M 10-Q · filed 2026-02-13 | ||
| 2025-06-30 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $2.26M derived: sum of 2 quarters · filed 2026-05-19 | $3.31M derived: sum of 3 quarters · filed 2026-05-19 | $3.61M 10-K · filed 2025-09-23 |
| 2025-03-31 | $802.00K 10-Q · filed 2026-05-19 | $1.86M derived: sum of 2 quarters · filed 2026-05-19 | $2.16M 10-Q · filed 2026-05-19 | $3.19M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $1.06M 10-Q · filed 2026-02-13 | $1.36M 10-Q · filed 2026-02-13 | $2.39M derived: sum of 3 quarters · filed 2026-02-13 | $2.67M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $301.00K 10-Q · filed 2025-11-12 | $1.33M derived: sum of 2 quarters · filed 2025-11-12 | $1.61M derived: sum of 3 quarters · filed 2025-11-12 | $2.04M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.31M derived: sum of 2 quarters · filed 2025-09-23 | $1.74M derived: sum of 3 quarters · filed 2025-09-23 | $3.02M 10-K · filed 2025-09-23 |
| 2024-03-31 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $705.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.98M 10-Q · filed 2025-05-14 | $2.27M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $1.71M 10-Q · filed 2025-02-14 | $1.99M derived: sum of 3 quarters · filed 2025-02-14 | $3.59M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $1.28M 10-Q · filed 2024-11-13 | $1.56M derived: sum of 2 quarters · filed 2024-11-13 | $3.16M derived: sum of 3 quarters · filed 2024-11-13 | $7.04M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $1.88M derived: sum of 2 quarters · filed 2024-09-27 | $5.76M derived: sum of 3 quarters · filed 2024-09-27 | $13.52M 10-K · filed 2024-09-27 |
| 2023-03-31 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $5.47M derived: sum of 2 quarters · filed 2024-05-14 | $13.24M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $11.64M 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | $7.77M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |